Sentences with phrase «acute diabetes complications»

Not exact matches

Prisons - Care of people with diabetes Diabetes UK is aware that many people with diabetes in institutional settings, such as prisons, can find it difficult to manage their diabetes successfully, to limit the development of acute metabolic problems such as hypoglycaemia, as well as disabling long - term complicdiabetes Diabetes UK is aware that many people with diabetes in institutional settings, such as prisons, can find it difficult to manage their diabetes successfully, to limit the development of acute metabolic problems such as hypoglycaemia, as well as disabling long - term complicDiabetes UK is aware that many people with diabetes in institutional settings, such as prisons, can find it difficult to manage their diabetes successfully, to limit the development of acute metabolic problems such as hypoglycaemia, as well as disabling long - term complicdiabetes in institutional settings, such as prisons, can find it difficult to manage their diabetes successfully, to limit the development of acute metabolic problems such as hypoglycaemia, as well as disabling long - term complicdiabetes successfully, to limit the development of acute metabolic problems such as hypoglycaemia, as well as disabling long - term complications..

Study findings indicate that among older adults who had diabetes for a shorter duration (9 years or less), nonfatal cardiovascular complications had the highest incidence (coronary artery disease, congestive heart failure, and cerebrovascular disease), followed by diabetic eye disease and acute hypoglycemic events.

The company's lead PEC - DirectTM product candidate is entering clinical development as a potential functional cure for patients with type 1 diabetes with the highest risk of life threatening acute complications.

The PEC - Direct product candidate is being developed for patients with high - risk type 1 diabetes, who often experience life - threatening acute complications, such as hypoglycemia unawareness and severe hypoglycemic episodes.

«We are excited to support the preclinical and clinical development work with the PEC - Direct product candidate, given its potential to help the type 1 diabetes patients with the most urgent medical need, those at high risk of life - threatening acute complications.

Used with concomitant maintenance immune suppression therapy, the PEC - Direct product has the potential of delivering a sustained, functional cure for patients with type 1 diabetes who are at high risk for acute life - threatening complications.

«JDRF is excited to support this clinical development given its potential to help those people with type 1 diabetes that need it the most — those at high risk of life - threatening acute complications.

San Diego, August 1, 2017 — ViaCyte, Inc., a privately - held, leading regenerative medicine company, announced today that the first patients have been implanted with the PEC - Direct ™ product candidate, a novel islet cell replacement therapy in development as a functional cure for patients with type 1 diabetes who are at high risk for acute life - threatening complications.

Exceptional glycemic control of type 1 diabetes without high rates of acute complications may be achievable among children and adults with a very low — carbohydrate diet.